peptalon - the science of better
Synferno Fatblaze - product image
Peptides Line

Synferno Fatblaze

Triple-action fat burner targeting stubborn areas through metabolic and mitochondrial activation.

Key Ingredients

GW501516, AOD9604

Not sure about the right dosage?

Use our Peptide Dosage Calculator for optimal application

Triple-action fat burner targeting stubborn areas through metabolic and mitochondrial activation.

Main Information

SYNFERNO FAT BLAZE is a next-generation fat loss catalyst designed for precision cutting and metabolic acceleration. It combines three synergistic compounds — SLU-PP-332, GW501516, and AOD9604 — each targeting different layers of fat metabolism, energy regulation, and recovery. Ideal for athletes in cutting phases, physique competitors, or anyone pursuing lean definition without sacrificing energy, endurance, or muscle.


Scientific Background

SYNFERNO FAT BLAZE brings together three cutting-edge compounds, each supported by distinct research and clinical pathways:

  • SLU-PP-332 (200 mcg) -A novel mitochondrial uncoupler that increases energy expenditure at the cellular level without affecting the nervous system. It works by gently increasing metabolic inefficiency in mitochondria — causing the body to burn more fat for heat without a rise in heart rate or stress hormone levels. Preclinical studies show significant fat reduction and improved endurance capacity.
  • GW501516 (5 mg)-Also known as Cardarine, this compound activates PPARδ, a nuclear receptor that regulates genes involved in fatty acid oxidation and glucose metabolism. GW501516 helps the body preferentially burn fat during training while sparing muscle tissue. Human and animal studies support its use for endurance enhancement and improved lipid profiles.
  • AOD9604 (100 mcg)-A modified fragment of human growth hormone (HGH 176–191) that retains fat-burning capabilities without affecting blood sugar or IGF-1 levels. It targets lipolytic pathways, making it ideal for localized and systemic fat reduction.Clinical studies demonstrate reduced body fat in both obese and healthy subjects.

Together, these three agents create a metabolic trifecta that works on fat oxidation, energy efficiency, and hormonal balance without overstimulation.


References

Wang XX, Myakala K, Libby AE, Krawczyk E, Panov J, Jones BA, Bhasin K, Shults N, Qi Y, Krausz KW, Zerfas PM, Takahashi S, Daneshpajouhnejad P, Titievsky A, Taranenko E, Billon C, Chatterjee A, Elgendy B, Walker JK, Albanese C, Kopp JB, Rosenberg AZ, Gonzalez FJ, Guha U, Brodsky L, Burris TP, Levi M. Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney. Am J Pathol. 2023 Dec;193(12):1969-1987. doi: 10.1016/j.ajpath.2023.07.008. Epub 2023 Sep 17. PMID: 37717940; PMCID: PMC10734281.
Dimopoulos N, Watson M, Green C, Hundal HS. The PPARdelta agonist, GW501516, promotes fatty acid oxidation but has no direct effect on glucose utilisation or insulin sensitivity in rat L6 skeletal muscle cells. FEBS Lett. 2007 Oct 2;581(24):4743-8. doi: 10.1016/j.febslet.2007.08.072. Epub 2007 Sep 6. PMID: 17869249.
Dimopoulos N, Watson M, Green C, Hundal HS. The PPARdelta agonist, GW501516, promotes fatty acid oxidation but has no direct effect on glucose utilisation or insulin sensitivity in rat L6 skeletal muscle cells. FEBS Lett. 2007 Oct 2;581(24):4743-8. doi: 10.1016/j.febslet.2007.08.072. Epub 2007 Sep 6. PMID: 17869249.

Usage Instructions

  • Inject subcutaneously (under the skin) using an insulin syringe into the abdomen, outer thigh, or upper glute area.
  • Rotate injection sites.
  • Best administered once daily, ideally in the morning fasted or 30–45 minutes before cardio.

Dosage Information

Fat-burning and recomposition:

  • 1 dose daily (contains 200 mcg SLU-PP-332, 5 mg GW501516, 100 mcg AOD9604)

Advanced metabolic enhancement:

  • 1–2 doses daily (morning + pre-workout)

Pre-contest / aggressive cutting phase:

  • 2 doses daily, monitored closely for individual tolerance and results

Cycle length: Recommended 6–8 weeks, followed by 2–4 weeks off


Important Warnings

  • Not suitable for pregnant or breastfeeding individuals
  • Avoid use if you have active or prior cancerous conditions
  • GW501516 is a banned substance in most professional sports — check regulatory status if competing
  • Mild fatigue or thermogenesis may occur in sensitive users
  • Always consult a healthcare professional before starting any injectable or multi-compound fat loss protocol

Frequently Asked Questions

What Others Have Selected